These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 21274687)

  • 1. Neuroimaging in Parkinson's disease.
    Stoessl AJ
    Neurotherapeutics; 2011 Jan; 8(1):72-81. PubMed ID: 21274687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging in Parkinson's disease: from pathology to diagnosis.
    Stoessl AJ
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S55-9. PubMed ID: 22166455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
    Meles SK; Oertel WH; Leenders KL
    Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging neurodegeneration in Parkinson's disease.
    Pavese N; Brooks DJ
    Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPECT molecular imaging in Parkinson's disease.
    Wang L; Zhang Q; Li H; Zhang H
    J Biomed Biotechnol; 2012; 2012():412486. PubMed ID: 22529704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging the Nonmotor Symptoms in Parkinson's Disease.
    Yousaf T; Wilson H; Politis M
    Int Rev Neurobiol; 2017; 133():179-257. PubMed ID: 28802921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging of nonmotor features of Parkinson's disease.
    Deblieck C; Wu AD
    Rev Neurol Dis; 2008; 5(3):125-33. PubMed ID: 18838952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional imaging in Parkinson disease.
    Nandhagopal R; McKeown MJ; Stoessl AJ
    Neurology; 2008 Apr; 70(16 Pt 2):1478-88. PubMed ID: 18413571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease.
    Sacheli MA; Neva JL; Lakhani B; Murray DK; Vafai N; Shahinfard E; English C; McCormick S; Dinelle K; Neilson N; McKenzie J; Schulzer M; McKenzie DC; Appel-Cresswell S; McKeown MJ; Boyd LA; Sossi V; Stoessl AJ
    Mov Disord; 2019 Dec; 34(12):1891-1900. PubMed ID: 31584222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease.
    Rolinski M; Griffanti L; Piccini P; Roussakis AA; Szewczyk-Krolikowski K; Menke RA; Quinnell T; Zaiwalla Z; Klein JC; Mackay CE; Hu MT
    Brain; 2016 Aug; 139(Pt 8):2224-34. PubMed ID: 27297241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional neuroimaging in Parkinson's disease.
    Niethammer M; Feigin A; Eidelberg D
    Cold Spring Harb Perspect Med; 2012 May; 2(5):a009274. PubMed ID: 22553499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neuroimaging in Parkinson's disease.
    Bidesi NSR; Vang Andersen I; Windhorst AD; Shalgunov V; Herth MM
    J Neurochem; 2021 Nov; 159(4):660-689. PubMed ID: 34532856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imaging of genetic aspects of Parkinson's disease].
    Brüggemann N; Vegt J; Klein C; Siebner HR
    Nervenarzt; 2010 Oct; 81(10):1196-203. PubMed ID: 20842341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.
    Barbagallo G; Caligiuri ME; Arabia G; Cherubini A; Lupo A; Nisticò R; Salsone M; Novellino F; Morelli M; Cascini GL; Galea D; Quattrone A
    Hum Brain Mapp; 2017 Sep; 38(9):4716-4729. PubMed ID: 28631404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.
    Arena JE; Stoessl AJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S47-51. PubMed ID: 26439947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional imaging in Parkinson's disease.
    Dagher A
    Semin Neurol; 2001; 21(1):23-32. PubMed ID: 11346022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease.
    Booij J; Knol RJ
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S425-8. PubMed ID: 18267276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.
    de Natale ER; Niccolini F; Wilson H; Politis M
    Int Rev Neurobiol; 2018; 141():131-172. PubMed ID: 30314595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical diagnosis of Parkinson's disease: are we there yet?
    Siderowf A; Stern MB
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):295-301. PubMed ID: 16822349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.